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Solid	Form	and	Solubility		
Christopher	A.	Hunter*a	and	Rafel	Prohensb	
Factors	that	determine	the	solubility	of	polymorphs	and	cocrystals	
are	analysed	using	experimental	data	to	show	that	the	change	in	
the	 solubility	 of	 a	 compound	 produced	 by	 the	 formation	 of	 a	
multicomponent	 crystal	 can	 be	 estimated	 in	 a	 straightforward	
manner,	if	the	solubilities	of	the	pure	compound	and	the	coformer	
are	known.	
Bioavailability1	 is	 one	 of	 the	 most	 important	 issues	 in	 the	
development	of	a	new	drug,	and	water	solubility2	is	one	of	the	
most	 important	 parameters	 that	 has	 an	 impact	 on	 the	 oral	
bioavailability.	Since	the	fraction	of	new	drug	candidates	with	
poor	water	solubility	is	very	high	(≈	70%),3	different	strategies	
are	being	pursued	to	develop	more	soluble	drugs.4	One	option	
is	 solid	 form	 modification.	 Amorphous	 materials	 and	
metastable	 polymorphs	 have	 relatively	 high	 solubilities,	 but	
these	 materials	 have	 associated	 risks,	 because	 they	 can	
transform	 into	 the	 most	 stable	 and	 less	 soluble	 polymorph	
during	formulation	or	in	storage.5	The	use	of	multicomponent	
crystals	 is	a	promising	approach	to	 improving	the	solubility	of	
an	 active	 pharmaceutical	 ingredient	 (API)	 as	 a	 stable	 solid	
form.6	However,	 the	number	of	potential	 coformers	available	
to	modify	solubility	is	very	high,	so	there	is	a	need	for	methods	
to	predict	which	compounds	are	 likely	 to	 form	cocrystals	and	
what	the	impact	on	solubility	is	likely	to	be.7	In	this	paper,	we	
use	experimental	data	to	investigate	the	relationship	between	
solubility	 and	 the	 free	 energy	 differences	 between	 different	
solid	forms.	
The	 free	 energy	 differences	 between	 different	 solid	 phases	
(polymorphs	or	cocrystals)	can	be	related	to	solubility	products	
in	 a	 specific	 solvent	 through	 the	 thermodynamic	 cycles	
depicted	in	Figure	1.	
	
Fig.	 1.	 Relationship	between	 solubility	products	 in	a	 specific	 solvent,	KS,	 and	 the	 free	
energy	difference	between	two	different	solid	forms,	∆G°,	at	a	given	temperature:	(a)	
two	polymorphs	of	compound	A	and	(b)	the	m:n	cocrystal	of	A	and	B.	
Thus	 in	 a	 polymorphic	 system	 the	 free	 energy	 difference	
between	 two	 polymorphs	 can	 be	 directly	 related	 to	 the	
difference	in	their	solubilities	(Figure	1a,	Equation	1).	∆𝐺° = −𝑅𝑇𝑙𝑛𝐾! + 𝑅𝑇𝑙n𝐾!!   Eq. 1 
Similarly	 in	 a	 two	 component	 cocrystal	 the	 free	 energy	
difference	between	the	cocrystal	and	the	pure	solid	phases	of	
the	components	can	be	related	to	the	difference	between	the	
solubility	 of	 the	 cocrystal	 and	 the	 solubilities	 of	 the	 pure	
components	(Figure	1b,	Equation	2).	
	Δ𝐺° = − !!!!𝑅𝑇𝑙𝑛𝐾! A − !!!!𝑅𝑇𝑙𝑛𝐾! B + !!!!𝑅𝑇𝑙𝑛𝐾!(A!𝐵!)
   Eq. 2 
where	m	 and	n	define	 the	cocrystal	 stoichiometry,	∆G°	 is	 the	
free	 energy	 change	 per	 total	 number	 of	 moles	 of	 the	 two	
components	 in	 the	 cocrystal	 (i.e.	 m+n),	 KS(AmBn)	 is	 the	
solubility	 product	 of	 the	 cocrystal	 in	 a	 specific	 solvent,	 and	
KS(A)	 and	 KS(B)	 are	 the	 solubility	 products	 of	 the	 pure	
components,	A	and	B,	in	the	same	solvent.	
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For	polymorphic	systems,	we	have	used	experimental	data	on	
the	 solubility	 of	 55	 different	 compounds	 compiled	 by	
Pudipeddi	et	al.8	For	cocrystals,	we	have	used	the	equilibrium	
cocrystal	 solubility	 data	 for	 25	 cocrystals	 reported	 by	
Rodriguez-Hornedo	et	al,9	because	these	measurements	avoid	
the	 potential	 problems	 associated	 with	 kinetically	 controlled	
processes.	 Free	 energy	 differences	 for	 these	 systems	 were	
calculated	using	Equations	1	and	2.	
	
Fig.	2.	Frequency	distribution	(N)	of	free	energy	differences	between	two	different	solid	
forms,	∆G°.	(a)	polymorphs	and	(b)	cocrystals	(the	data	in	(a)	are	symmetrical	about	the	
origin	because	either	of	the	two	forms	can	be	used	as	the	reference	state).	
Figure	 2a	 shows	 the	 distribution	 values	 of	 ∆G°	 for	 the	 55	
polymorphic	 systems.	 The	 free	 energy	 difference	 between	
polymorphs	is	generally	small	(≤	2	kJ	mol-1),	and	the	solubilities	
of	two	polymorphs	of	the	same	compound	tend	to	be	within	a	
factor	 of	 2.	 This	 result	 highlights	 the	 difficulty	 in	 reliably	
predicting	 crystal	 structures	 using	 energy-based	 approaches,	
because	 extremely	 high	 accuracy	 is	 required.	 However,	 the	
prediction	 of	 physical	 properties	 like	 solubility	 is	 more	
straightforward,	 because	 in	 most	 cases	 the	 precise	 three-
dimensional	 arrangement	 of	 the	 molecules	 in	 the	 crystal	
structure	does	not	have	a	major	impact	on	the	free	energy	of	
the	 solid	 (differences	 in	 solubility	 of	 a	 factor	 of	 5	 have	 been	
reported	 with	 significant	 impact	 on	 formulation	 of	 the	 API).	
The	 free	 energy	 of	 a	 crystalline	 solid	 depends	 largely	 on	 the	
energies	 of	 the	 functional	 group	 interactions	 that	 are	 made,	
and	 many	 different	 crystal	 structure	 arrangements	 (or	
polymorphs)	 can	 accommodate	 the	 same	 set	 of	 functional	
group	 interactions,	 or	 alternative	 combinations	 of	 equi-
energetic	functional	group	interactions.	
Figure	 2b	 shows	 the	 distribution	 values	 of	 ∆G°	 for	 the	 25	
cocrystal	 systems.	 These	 data	 are	 clearly	 different	 from	 the	
polymorph	 systems.	 In	 all	 cases,	 ∆G°	 is	 negative,	 i.e.	 the	
cocrystals	 are	more	 stable	 than	 the	 pure	 components,	which	
presumably	 reflects	 attractive	 inter-component	 interactions	
that	are	not	possible	in	the	pure	forms.	The	magnitudes	of	the	
free	 energy	 differences	 tend	 to	 be	 larger	 than	 found	 for	
polymorphs	 (≥	2	kJ	mol-1),	and	 there	 is	a	broader	distribution	
of	 values.	 Again	 this	 reflects	 the	 fact	 that	 the	 intermolecular	
interactions	 that	 are	 possible	 in	 the	 cocrystal	 are	 different	
from	 those	 found	 in	 the	 pure	 components,	 which	 is	 not	 the	
case	for	polymorphs.	
The	 observations	 in	 Figure	 2	 have	 important	 implications	 for	
energy-based	 approaches	 to	 cocrystal	 prediction.	 The	
differences	 between	 the	 energies	 of	 the	 functional	 group	
interactions	 in	 a	 cocrystal	 relative	 to	 the	 pure	 solid	 forms	
(Figure	 2b)	 tend	 to	 be	 significantly	 larger	 than	 the	 energetic	
differences	due	to	the	precise	three-dimensional	arrangement	
of	molecules	 in	 crystal	 structures	 (Figure	2a).	 In	other	words,	
accurate	 crystal	 structure	 prediction	 is	 not	 required	 for	
accurate	prediction	of	the	probability	of	cocrystal	formation.	
In	 addition	 to	 prediction	 of	which	 systems	 are	 likely	 to	 form	
cocrystals,	 it	 would	 also	 be	 useful	 to	 be	 able	 to	 predict	 the	
effects	of	cocrystal	formation	on	solubility.	Cocrystal	solubility	
depends	 on	 the	 physical	 properties	 of	 the	 coformer	 and	
cocrystal	 stoichiometry	 as	 well	 as	 the	 free	 energy	 difference	
between	 the	 solid	 forms	 discussed	 above.	 The	 cocrystal	
solubility	product	can	be	written	in	terms	of	the	concentration	
of	component	A	in	equilibrium	with	the	solid	(Equation	3).	𝐾! A!B! = A ! B ! = !! ! A !!!  Eq. 3 
If	we	define	 this	 quantity	 as	 the	 cocrystal	 solubility	 of	A,	SCC,	
substitute	 into	 Equation	2	 to	 give	 Equation	4,	 and	 rearrange,	
the	 change	 in	 the	 solubility	 of	 A	 associated	 with	 cocrystal	
formation	can	be	written	as	Equation	5.	Δ𝐺° = − !!!!𝑅𝑇𝑙𝑛𝑆!− !!!!𝑅𝑇𝑙𝑛𝑆!− !!!!𝑅𝑇𝑙𝑛 !! +𝑅𝑇𝑙𝑛𝑆!!
   Eq. 4 log !!!!! = !!!! log !!!! + !!°!.!"!!" + !!!! log !!   Eq. 5 
Equation	 5	 describes	 how	 the	 change	 in	 the	 solubility	 of	 a	
compound	upon	cocrystal	formation	is	related	to	the	solubility	
of	 the	 coformer,	 the	 cocrystal	 stoichiometry	 and	 the	 free	
energy	 difference	 between	 the	 cocrystal	 and	 the	 pure	
components.	The	experimental	cocrystal	data	shown	in	Figure	
2b	suggest	that	∆G°	tends	to	be	of	the	order	of	a	few	kJ	mol-1,	
so	 it	 is	 possible	 to	 plot	 limiting	 theoretical	 relationships	
between	 cocrystal	 solubility	 (SCC)	 and	 coformer	 solubility	 (SB)	
for	different	 cocrystal	 stoichiometries	by	assuming	a	 value	of	
zero	 for	 ∆G°	 (Figure	 3a).	 In	 general,	 the	 solubility	 of	 a	
compound	is	increased	by	formation	of	a	cocrystal	with	a	more	
soluble	coformer	(and	vice	versa).	The	effect	can	be	amplified	
by	 forming	 a	 cocrystal	 with	 a	 higher	 stoichiometric	 ratio	 of	
coformer	 (and	 vice	 versa).	 The	 relationships	 in	 Figure	 3a	
provide	 an	 upper	 limit	 on	 the	 solubility	 of	 a	 cocrystal,	 and	
given	the	distribution	of	∆G°	values	 in	Figure	2b,	these	values	
are	 likely	 to	 be	 accurate	 to	 within	 an	 order	 of	 magnitude.	
Figure	3b	compares	the	limiting	theoretical	relationship	for	1:1	
cocrystals	with	the	experimental	data.	All	of	the	experimental	
data	fall	within	an	order	of	magnitude	of	the	theoretical	upper	
limit	for	cocrystal	solubility.	
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Fig.	3.	The	relationship	between	the	change	in	the	solubility	of	compound	A	associated	
with	 cocrystal	 formation	 (SCC/SA)	 and	 the	 solubility	 of	 the	 coformer	 (SB/SA):	 (a)	 for	
stoichiometries	 (m:n)	of	1:3	 (pale	red),	1:2	 (dark	red),	1:1	 (black),	2:1	 (dark	blue),	3:1	
(pale	 blue).	 (b)	 Comparison	 of	 experimental	 data	 points	with	 the	 limiting	 theoretical	
value	 of	 cocrystal	 solubility	 (the	 solid	 line	 represents	 the	 upper	 limit	 of	 cocrystal	
solubility,	∆G°	=	0,	and	the	dashed	line	is	one	order	of	magnitude	lower).	
The	 good	 correlation	 between	 the	 theoretical	 line	 and	 the	
experimental	 data	 in	 Figure	 3b	 indicates	 that	 it	 should	 be	
possible	 to	 design	 cocrystals	 with	 a	 desired	 solubility	
properties,	provided	the	solubilities	of	the	potential	coformers	
are	 known.	 If	 there	 is	 a	 large	 difference	 between	 the	
solubilities	of	the	two	components	of	a	cocrystal,	the	impact	of	
small	differences	between	the	free	energies	of	the	solid	forms	
will	be	relatively	unimportant.	This	is	particularly	significant	in	
the	 pharmaceutical	 context,	 because	 the	 water	 solubility	 of	
most	APIs	 is	 low,	and	the	solubilities	of	coformers	 tend	to	be	
much	 higher.	 Equation	 5	 suggests	 that	 in	 general	 we	 should	
expect	 the	 solubility	 of	 a	 compound	 in	 a	 1:1	 cocrystal	 to	
increase	 in	 proportion	 to	 the	 square	 root	 of	 the	 solubility	 of	
the	 coformer,	 and	 this	 is	 confirmed	 by	 the	 data	 plotted	 in	
Figure	2b.	
Conclusions	
The	 analysis	 presented	 here	 leads	 to	 some	 general	
conclusions,	 which	may	 be	 useful	 in	 the	 design	 of	 new	 solid	
forms	of	compounds	with	the	desired	solubility	properties:	
	
1.	 The	 free	 energy	 differences	 between	 polymorphs	 (i.e.	
different	packing	motifs)	are	generally	small	(≤	2	kJ	mol-1).	
2.	The	free	energy	differences	between	cocrystals	and	the	pure	
component	solids	 (i.e.	different	 functional	group	 interactions)	
are	larger	(≥	2	kJ	mol-1).	
3.	 The	 solubilities	 of	 compounds	 formulated	 as	 cocrystals	
increase	in	proportion	to	the	solubility	of	the	coformer.9	
4.	 The	 effects	 of	 coformers	 on	 the	 solubilities	 of	 cocrystals	
increase	 in	proportion	to	the	stoichiometric	ratio	of	coformer	
in	the	cocrystal.	
5.	The	free	energy	differences	between	cocrystals	and	the	pure	
component	 solids	 have	 a	 relatively	 small	 effect	 on	 cocrystal	
solubility	(less	than	an	order	of	magnitude).	
	
Observations	 1	 and	 2	 suggest	 that	 approaches	 to	 coformer	
selection	 that	 rely	 on	 simple	 calculations	 of	 functional	 group	
interaction	energies	rather	than	the	computationally	intensive	
methods	required	for	accurate	crystal	structure	prediction	are	
likely	to	be	successful.	Observations	3-5	suggest	that	provided	
the	 solubilities	 of	 the	pure	 components	 are	 known,	 it	will	 be	
straightforward	 to	 estimate	 the	 effect	 of	 formulation	 of	 a	
compound	 as	 a	 cocrystal	 on	 solubility	 (at	 least	 to	 within	 an	
order	of	magnitude).	
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